Javascript must be enabled to continue!
1260-P: Verifying the Use of FIB4 and BARD Scores to Predict Advanced Fibrosis Using Transient Elastography in People with Type 2 Diabetes in a Tertiary Care Center in India
View through CrossRef
Background: There is a high prevalence of nonalcoholic fatty liver disease in people with type 2 diabetes. Liver biopsy is the gold standard for diagnosing advanced fibrosis but is usually not feasible in routine clinical practice. Transient elastography is accepted as a viable non-invasive alternative but is not universally available due to high cost. FIB4 and BARD scores are easy to perform in routine clinical practice and can guide for referral for transient elastography or liver biopsy. The aim of this study was to assess the utility of these simple scores (FIB4 and BARD) to exclude advanced fibrosis in people with type 2 diabetes.
Material and Methods: A total of 133 consenting people were subjected to fibro scan. Serum markers (AST, ALT, Platelet count) were measured, and FIB 4 and BARD scores were calculated using standard equations. LSM (liver stiffness measurement) cut-off value of 11.4 was used to exclude advanced fibrosis.
Results: Out of 133 people with diabetes in the study, 51.1% males and 48.9% were females, with a mean age of 50years, BMI 26.6, hba1c 8.7%, duration of diabetes 7.6yrs. The average LSM was 9.1, mean AST was 36 U/ml and ALT 38.5U/ml, platelet count was 208cubic mm. Mean FIB4 score was1.7 and BARD score was 3. 82.7% had a LSM value of <11.5 and 17.3% had a LSM value of>11.5%, neither BARD score nor FIB4 had significant correlation with liver stiffness measurement. Fib4 had a (Negative predictive value) NPV of 83.6% and BARD score had a NPV of 85.7% to exclude advanced fibrosis (>11.4)
Conclusion: A FIB 4 score of less than 2.6 and BARD score of less than 2 have a high negative predictive value to exclude advanced fibrosis. Due to the high incidence of NAFLD in people with diabetes, these should be routinely used to exclude advanced fibrosis and the decision to referral for fibro scans and liver biopsy.
Disclosure
A. Tewari: None. J. Tewari: None. A. Maheshwari: None. V. Tewari: None. B. Tewari: None.
American Diabetes Association
Title: 1260-P: Verifying the Use of FIB4 and BARD Scores to Predict Advanced Fibrosis Using Transient Elastography in People with Type 2 Diabetes in a Tertiary Care Center in India
Description:
Background: There is a high prevalence of nonalcoholic fatty liver disease in people with type 2 diabetes.
Liver biopsy is the gold standard for diagnosing advanced fibrosis but is usually not feasible in routine clinical practice.
Transient elastography is accepted as a viable non-invasive alternative but is not universally available due to high cost.
FIB4 and BARD scores are easy to perform in routine clinical practice and can guide for referral for transient elastography or liver biopsy.
The aim of this study was to assess the utility of these simple scores (FIB4 and BARD) to exclude advanced fibrosis in people with type 2 diabetes.
Material and Methods: A total of 133 consenting people were subjected to fibro scan.
Serum markers (AST, ALT, Platelet count) were measured, and FIB 4 and BARD scores were calculated using standard equations.
LSM (liver stiffness measurement) cut-off value of 11.
4 was used to exclude advanced fibrosis.
Results: Out of 133 people with diabetes in the study, 51.
1% males and 48.
9% were females, with a mean age of 50years, BMI 26.
6, hba1c 8.
7%, duration of diabetes 7.
6yrs.
The average LSM was 9.
1, mean AST was 36 U/ml and ALT 38.
5U/ml, platelet count was 208cubic mm.
Mean FIB4 score was1.
7 and BARD score was 3.
82.
7% had a LSM value of <11.
5 and 17.
3% had a LSM value of>11.
5%, neither BARD score nor FIB4 had significant correlation with liver stiffness measurement.
Fib4 had a (Negative predictive value) NPV of 83.
6% and BARD score had a NPV of 85.
7% to exclude advanced fibrosis (>11.
4)
Conclusion: A FIB 4 score of less than 2.
6 and BARD score of less than 2 have a high negative predictive value to exclude advanced fibrosis.
Due to the high incidence of NAFLD in people with diabetes, these should be routinely used to exclude advanced fibrosis and the decision to referral for fibro scans and liver biopsy.
Disclosure
A.
Tewari: None.
J.
Tewari: None.
A.
Maheshwari: None.
V.
Tewari: None.
B.
Tewari: None.
Related Results
Physical Principles of Elastography: A Primer for Radiologists
Physical Principles of Elastography: A Primer for Radiologists
AbstractElastography is the noninvasive method of qualitative and quantitative evaluation of strain and elastic modulus distribution in soft tissues. In simpler terms, elastography...
Transient Hepatic Elastography in the Assessment of Liver Fibrosis in Patients After Liver Transplantation
Transient Hepatic Elastography in the Assessment of Liver Fibrosis in Patients After Liver Transplantation
Introduction and Objectives. Liver biopsy is the gold standard for assessing fibrosis and inflammation in liver transplant recipients. As this study has risks, the use of noninvasi...
The Use of Ultrasound-Based Elastography Techniques in Liver Fibrosis: A Narrative Review
The Use of Ultrasound-Based Elastography Techniques in Liver Fibrosis: A Narrative Review
Background: Liver fibrosis staging plays a key role in the prognosis and management of chronic liver disease. Liver biopsy remains the reference standard for fibrosis assessment bu...
The Use of Ultrasound-Based Elastography Techniques in Liver Fibrosis: A Narrative Review
The Use of Ultrasound-Based Elastography Techniques in Liver Fibrosis: A Narrative Review
Liver fibrosis staging plays a key role in the prognosis and management of chronic liver disease. Liver biopsy remains the reference standard for fibrosis assessment but is limited...
P0364 MR Elastography Characterizing Biomechanical Properties to Enhance Enterographic Fibrosis Diagnosis
P0364 MR Elastography Characterizing Biomechanical Properties to Enhance Enterographic Fibrosis Diagnosis
Abstract
Background
Current diagnostic tools for fibrosis assessment in Crohn’s disease (CD) remain suboptimal.[1] MR ela...
Evaluating the effect of direct-acting agents on liver fibrosis, by real-time elastography, Fibroscan and FIB4 score in chronic HCV patients
Evaluating the effect of direct-acting agents on liver fibrosis, by real-time elastography, Fibroscan and FIB4 score in chronic HCV patients
Background
One of the most important questions is what happens with liver fibrosis following a sustained virological response (SVR), although the current anti-HCV thera...
Evaluation of non-invasive markers of liver fibrosis in chronic hepatitis B patients in a sub- saharan African setting: Transient elastography Versus APRI, FIB4, GTT/ Platelet scores
Evaluation of non-invasive markers of liver fibrosis in chronic hepatitis B patients in a sub- saharan African setting: Transient elastography Versus APRI, FIB4, GTT/ Platelet scores
Abstract
Background: Non-invasive markers which use routine laboratory tests are less expensive and highly needed to assess and stage liver fibrosis in chronic hepatitis B ...
Organisatie van geestelijke gezondheidszorg voor mensen met een ernstige en persisterende mentale aandoening
Organisatie van geestelijke gezondheidszorg voor mensen met een ernstige en persisterende mentale aandoening
1 INTRODUCTION AND RESEARCH QUESTIONS 5 -- 2 GENERAL BACKGROUND: DEFINITIONS AND SCOPE OF THE STUDY 7 -- 2.1 CHRONIC AND COMPLEX MENTAL DISORDERS: DEFINITIONS AND SCOPE OF THE -- S...

